Claudia Dos Santos
Professor
Molecular Biology
University of Toronto
Canada
Biography
Claudia dos Santos MD, MSc, FRCPC Associate Professor Contact information Division of Respirology St. Michael's Hospital 30 Bond St., Rm 4-008 Bond Wing Toronto Ontario M5B 1W8 Phone: 416-864-6060 Ext: 3198 Fax: Email: dossantosc@smh.ca Research location: St. Michael's Hospital/Research Institute Primary Research Area: Molecular & Cell Biology Secondary Research Area: Infectious Diseases & Immunopathology Research Statement: My laboratory focuses on developing integrated systems biology and functional genomics approaches to: (1) understanding molecular mechanisms of acute multiple organ failure (HEART and LUNG) in the critically ill (sepsis and acute respiratory distress syndrome ARDS), and (2) developing an “informed” approach to the discovery of novel molecular targets for therapy including stem cell and gene therapy. Claudia dos Santos MD, MSc, FRCPC Associate Professor Contact information Division of Respirology St. Michael's Hospital 30 Bond St., Rm 4-008 Bond Wing Toronto Ontario M5B 1W8 Phone: 416-864-6060 Ext: 3198 Fax: Email: dossantosc@smh.ca Research location: St. Michael's Hospital/Research Institute Primary Research Area: Molecular & Cell Biology Secondary Research Area: Infectious Diseases & Immunopathology Research Statement: My laboratory focuses on developing integrated systems biology and functional genomics approaches to: (1) understanding molecular mechanisms of acute multiple organ failure (HEART and LUNG) in the critically ill (sepsis and acute respiratory distress syndrome ARDS), and (2) developing an “informed” approach to the discovery of novel molecular targets for therapy including stem cell and gene therapy.
Research Interest
My laboratory focuses on developing integrated systems biology and functional genomics approaches to: (1) understanding molecular mechanisms of acute multiple organ failure (HEART and LUNG) in the critically ill (sepsis and acute respiratory distress syndrome ARDS), and (2) developing an “informed” approach to the discovery of novel molecular targets for therapy including stem cell and gene therapy.
